🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for Non Valvular Atrial Fibrillation

Development of CIRC Technologies NCT05654272n/a1 site📍 Cleveland The Cleveland Clinic · Tests: MRI Applause Study I - Append System Early Feasibility Study NCT07278869NA3 sites📍 Jonesboro📍 Los Angeles📍 New York Append Medical Ltd. · Tests: Left Atrial Appendage Elimination: Append System Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. NCT04298723NA39 sites📍 Mannheim📍 Bad Neustadt an der Saale📍 Burgau Jena University Hospital · Tests: Percutaneous closure of the LAA (Watchman / Watchman FLX) Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation NCT06187311Phase 41 site📍 Seoul Korea University Anam Hospital · Tests: Rivaroxaban 20 MG, Rivaroxaban 15 MG Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion NCT06949319n/a1 site📍 Esbjerg Nedim Tojaga Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events NCT04559243n/a5 sites📍 Jinan📍 Shanghai📍 Mianyang Lifetech Scientific (Shenzhen) Co., Ltd. · Tests: Transthoracic Echocardiography Append Prague Study NCT07816029NA1 site📍 Prague Append Medical Ltd. · Tests: Append System Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding NCT04701749n/a1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: Percutaneous left atrial closure, No Percutaneous left atrial closure FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients NCT07385599NA1 site📍 Shatin Lifetech Scientific (Shenzhen) Co., Ltd. · Tests: LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry NCT05598632n/a1 site📍 Beijing China National Center for Cardiovascular Diseases Longitudinal Validation of CIRC Technologies NCT07081711n/a1 site📍 Cleveland The Cleveland Clinic Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure NCT06465459n/a1 site📍 Pessac French Cardiology Society · Tests: LAMBRE device implantation Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation NCT02741349n/a4 sites📍 Paris📍 Paris📍 Saint-Denis Saint Antoine University Hospital Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI NCT04695106Phase 41 site📍 Gdansk Medical University of Gdansk · Tests: Ticagrelor, Dabigatran Etexilate, Aspirin, Clopidogrel Optimized Expansion of the Implanted Transcatheter Aortic Valve NCT07042529NA17 sites📍 Aalst📍 Charleroi📍 Leuven Ole De Backer · Tests: OptEx-TAVI, SoC-TAVI Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease NCT05204212NA1 site📍 Lübeck Prof. Dr. med. Ingo Eitel · Tests: Left Atrial Appendage closure
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy